Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics.
Pruthvi C RevaiahRakesh KochharSurinder V RanaNeha BerryMunish AshatNarendra DhakaY Rami ReddySaroj Kant SinhaPublished in: JGH open : an open access journal of gastroenterology and hepatology (2018)
The use of prokinetics in patients on PPI may reduce the risk of SIBO by enhancing intestinal motility and may reduce SIBO risk associated with long-term PPI use.